Clerch L B, Whitney P L, Massaro D
Pulmonary Research Laboratories, Calvin and Flavia Oak Asthma Research and Treatment Facility, University of Miami School of Medicine, FL 33136.
Biochem J. 1987 Aug 1;245(3):683-90. doi: 10.1042/bj2450683.
Soluble lectins are widely distributed cell-agglutinating proteins. Their activity is developmentally regulated in several tissues, including the lung, but virtually nothing is known about the mechanisms of the developmental regulation or the turnover of these proteins. We studied mechanisms that might be responsible for the developmentally regulated changes in the activity of a lectin (beta-galactoside-binding protein) found in the lung, and determined if its activity or turnover could be modulated by treatment of rat pups with a glucocorticosteroid hormone (dexamethasone). Our studies on the activity and turnover of the lectin indicated that the peak of lectin activity (units/mg of protein) that occurred at age 12 days appeared to be brought about by two means: an increase in the activity of the lectin molecule itself (units/micrograms of lectin) that occurred at age 8 days, and 1.5-fold increase in the absolute rate of lectin synthesis at age 11 days. The decline in lectin activity was associated with a decrease in its rate of synthesis, return to the baseline extent of activation, and an increased rate of degradation. Treatment of rat pups with dexamethasone diminished the peak of lectin activity (units/mg of protein) by about 25%. This effect of dexamethasone was due, at least in part, to the complete prevention of activation of the lectin molecule (units/micrograms of lectin) and a premature increase in the rate of lectin degradation. Perhaps the normal fall in lectin activity after age 11 days is caused by mechanisms induced by the increase in serum corticosteroid that occurs at that age.
可溶性凝集素是广泛分布的细胞凝集蛋白。它们的活性在包括肺在内的多种组织中受到发育调控,但对于这些蛋白发育调控的机制或其更新情况几乎一无所知。我们研究了可能导致肺中发现的一种凝集素(β-半乳糖苷结合蛋白)活性发生发育调控变化的机制,并确定用糖皮质激素(地塞米松)处理幼鼠是否能调节其活性或更新。我们对该凝集素活性和更新的研究表明,12日龄时出现的凝集素活性峰值(单位/毫克蛋白)似乎是由两种方式引起的:8日龄时凝集素分子本身的活性增加(单位/微克凝集素),以及11日龄时凝集素合成绝对速率增加1.5倍。凝集素活性的下降与其合成速率降低、激活程度恢复到基线水平以及降解速率增加有关。用地塞米松处理幼鼠可使凝集素活性峰值(单位/毫克蛋白)降低约25%。地塞米松的这种作用至少部分是由于完全阻止了凝集素分子的激活(单位/微克凝集素)以及凝集素降解速率过早增加。也许11日龄后凝集素活性的正常下降是由该年龄时血清皮质类固醇增加所诱导的机制引起的。